Haiyong Han

9.9k total citations · 3 hit papers
114 papers, 7.1k citations indexed

About

Haiyong Han is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Haiyong Han has authored 114 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 55 papers in Oncology and 25 papers in Cancer Research. Recurrent topics in Haiyong Han's work include Pancreatic and Hepatic Oncology Research (32 papers), Advanced biosensing and bioanalysis techniques (15 papers) and RNA Interference and Gene Delivery (14 papers). Haiyong Han is often cited by papers focused on Pancreatic and Hepatic Oncology Research (32 papers), Advanced biosensing and bioanalysis techniques (15 papers) and RNA Interference and Gene Delivery (14 papers). Haiyong Han collaborates with scholars based in United States, China and United Kingdom. Haiyong Han's co-authors include Daniel D. Von Hoff, Laurence H. Hurley, Galen Hostetter, David J. Bearss, Clifford J. Whatcott, Miguel Salazar, Rubén M. Muñoz, Aditi Bapat, Daekyu Sun and Richard T. Wheelhouse and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Haiyong Han

112 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer

2015 469 citations Clifford J. Whatcott, Caroline H. Diep et al. Clinical Cancer Research profile →
Perineural invasion and associated pain in pancreatic cancer

2011 349 citations Galen Hostetter, Daniel D. Von Hoff et al. profile →
Triptolide and Its Derivatives as Cancer Therapies

2019 233 citations Daniel D. Von Hoff, Erkut Borazanci et al. profile →

Peers

Countries citing papers authored by Haiyong Han

Since Specialization

Citations

This map shows the geographic impact of Haiyong Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyong Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyong Han more than expected).

Fields of papers citing papers by Haiyong Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiyong Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyong Han. The network helps show where Haiyong Han may publish in the future.

Co-authorship network of co-authors of Haiyong Han

This figure shows the co-authorship network connecting the top 25 collaborators of Haiyong Han. A scholar is included among the top collaborators of Haiyong Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiyong Han. Haiyong Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Therapeutic Plasma Exchange: Current and Emerging Applications to Mitigate Cellular Signaling in Disease 2025 ·Biomolecules ·(unknown), (unknown), (unknown), (unknown), Rachael Mooney, Zhen Chen, Tristan Scott, Haiyong Han, (unknown), (unknown), Wendong Huang, Adolfo Garcı́a-Ocaña, Maria B. Grant, Karen S. Aboody, Daniel D. Von Hoff, Rama Natarajan, Joshua D. Tompkins	2
2	Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer 2024 ·Pharmaceuticals ·Yuan Li, Caiming Xu, Haiyong Han, (unknown), Cristina Fillat, Ajay Goel	6
3	Abstract 2497: Extracellular vesicle based ALPPL2 and THBS2 as biomarkers for disease monitoring in patients with pancreatic ductal adenocarcinoma 2024 ·Cancer Research ·(unknown), Gayle Jameson, Erkut Borazanci, Wei Lin, (unknown), Daniel D. Von Hoff, Haiyong Han	0
4	Advanced glycation end product (AGE) targeting antibody SIWA318H is efficacious in preclinical models for pancreatic cancer 2023 ·Scientific Reports ·Gabriela R. Rossi, Ashley W. Jensen, Serina Ng, Zhirong Yin, Aimin Li, Anjan Misra, Daniel D. Von Hoff, (unknown), (unknown), Haiyong Han	2
5	Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β2 adrenergic agonist 2022 ·Scientific Reports ·Artur Wnorowski, Danuta Dudzik, Michel Bernier, (unknown), Guido Keijzers, Alberto Díaz‐Ruiz, (unknown), Yongqing Zhang, Haiyong Han, Morten Scheibye‐Knudsen, Krzysztof Jóźwiak, Coral Barbas, Irving W. Wainer	8
6	Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL 2022 ·Cancer Research ·Russell Moser, James Annis, Olga Nikolova, (unknown), Kay E. Gurley, Eduardo Méndez, Kim Moran‐Jones, Craig Dorrell, Rosalie C. Sears, Calvin J. Kuo, Haiyong Han, Andrew V. Biankin, Carla Grandori, Daniel D. Von Hoff, Christopher J. Kemp	4
7	Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth 2022 ·Med ·Lifeng Yang, Tara TeSlaa, Serina Ng, Michel Nofal, Lin Wang, Taijin Lan, Xianfeng Zeng, Alexis J. Cowan, Matthew J. McBride, Wenyun Lu, Shawn M. Davidson, Gaoyang Liang, Tae Gyu Oh, Michael Downes, Ronald M. Evans, Daniel D. Von Hoff, Jessie Yanxiang Guo, Haiyong Han, Joshua D. Rabinowitz	72
8	Increasing Stress to Induce Apoptosis in Pancreatic Cancer via the Unfolded Protein Response (UPR) 2022 ·International Journal of Molecular Sciences ·(unknown), Max Miller, Pedro Luiz Serrano Usón, (unknown), Haiyong Han, Daniel D. Von Hoff	20
9	Effect of acoustic cluster therapy (ACT®) combined with chemotherapy in a patient-derived xenograft mouse model of pancreatic cancer 2022 ·Journal of Controlled Release ·Serina Ng, (unknown), Per Christian Sontum, (unknown), Sverre H. Torp, Einar Sulheim, Daniel D. Von Hoff, Haiyong Han	6
10	Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression 2018 ·Clinical Cancer Research ·Xiaoming Li, H. Michael Shepard, (unknown), Chun‐Mei Zhao, Ryan J. Osgood, Sanna Rosengren, Barbara Blouw, (unknown), Mark D. Pagel, Clifford J. Whatcott, Haiyong Han, Daniel D. Von Hoff, Darin Taverna, Michael J. LaBarre, Daniel C. Maneval, Curtis B. Thompson	69
11	Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer breakdown → 2015 ·Clinical Cancer Research ·Clifford J. Whatcott, Caroline H. Diep, Ping Jiang, Aprill Watanabe, Janine LoBello, Chao Sima, Galen Hostetter, H. Michael Shepard, Daniel D. Von Hoff, Haiyong Han	469
12	Molecular Characterization of a Patient's Small Cell Carcinoma of the Ovary of the Hypercalcemic Type 2012 ·Journal of Cancer ·Bret J. Stephens, Stephen P. Anthony, Haiyong Han, (unknown), Galen Hostetter, M C Barrett, Daniel D. Von Hoff	11
13	Synergistic Effect between Erlotinib and MEK Inhibitors in KRAS Wild-Type Human Pancreatic Cancer Cells 2011 ·Clinical Cancer Research ·Caroline H. Diep, Rubén M. Muñoz, Ashish Choudhary, Daniel D. Von Hoff, Haiyong Han	66
14	Enhanced targeting with heterobivalent ligands 2009 ·Molecular Cancer Therapeutics ·Liping Xu, Josef Vágner, J.S. Josan, Ronald M. Lynch, David L. Morse, Brenda Baggett, Haiyong Han, Eugene A. Mash, Victor J. Hruby, Robert J. Gillies	46
15	UA62784, a novel inhibitor of centromere protein E kinesin-like protein 2009 ·Molecular Cancer Therapeutics ·Meredith C. Henderson, (unknown), Hong Wang, Haiyong Han, Laurence H. Hurley, Gary A. Flynn, Robert T. Dorr, Daniel D. Von Hoff	42
16	Validation of TPX2 as a Potential Therapeutic Target in Pancreatic Cancer Cells 2009 ·Clinical Cancer Research ·Steven L. Warner, Bret J. Stephens, (unknown), Galen Hostetter, (unknown), Manuel Hidalgo, Jeffery M. Trent, Haiyong Han, Daniel D. Von Hoff	86
17	Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer 2008 ·Molecular Cancer Therapeutics ·Yoganand Balagurunathan, David L. Morse, Galen Hostetter, Vijayalakshmi Shanmugam, Phillip Stafford, Sonsoles Shack, John V. Pearson, Maria Trissal, Michael J. Demeure, Daniel D. Von Hoff, Victor J. Hruby, Robert J. Gillies, Haiyong Han	20
18	Inhibition of XIAP expression sensitizes pancreatic cancer cells to gemcitabine 2007 ·Molecular Cancer Therapeutics ·Caroline H. Diep, Daniel D. Von Hoff, Haiyong Han	1
19	Identification of an Agent Selectively Targeting DPC4 (Deleted in Pancreatic Cancer Locus 4)–Deficient Pancreatic Cancer Cells 2006 ·Cancer Research ·Hong Wang, Haiyong Han, Daniel D. Von Hoff	58
20	A DNA polymerase stop assay for G-quadruplex-interactive compounds 1999 ·Nucleic Acids Research ·Haiyong Han, Laurence H. Hurley, Miguel Salazar	208

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact